IGF-1 LR3

Insulin-like Growth Factor-1 Long R3

A long-acting analog of IGF-1 with enhanced receptor binding and extended half-life for anabolic and recovery effects.

100% 50% · t½ Time → Serum level
Molecular Weight
9117.5 Da
Half-Life
~20 hours
Typical Dose
20–100 mcg
Cycle Length
4–6 weeks (with breaks)

Description

IGF-1 LR3 is a recombinant analog of insulin-like growth factor-1 with an arginine substitution at position 3 and an N-terminal 13 amino acid extension. These modifications reduce binding to IGF-binding proteins, extending its half-life from ~12 minutes to ~20 hours and enhancing its biological activity.

Key Characteristics

Molecular FormulaC400H625N111O115S9
Molecular Weight9117.5 Da
Half-Life~20 hours
Administration RoutesSubcutaneous injection, Intramuscular injection
Typical Dose20–100 mcg
FrequencyDaily or every other day
Cycle Length4–6 weeks (with breaks)

Investigated Benefits

  • Enhanced muscle protein synthesis
  • Accelerated muscle recovery
  • Improved body composition
  • Anti-aging effects
  • Neuroprotection

* Benefits based on preclinical/animal research unless otherwise noted.